BREAKING NEWS APRIL 15, 2026 - In a welcome announcement to the SSRP community, the FDA reported today that it will imminently remove the following bulk drug substances from category 2: BPC-157, LL-37, DiHexa, DSIP, Epitalon, *GHK-Cu (injectable only), KPV, PEG-MGF, Melanotan II, MOTs-C, Semax, and TB-500
Medications requiring rapid absorption like pain relievers may work more slowly
a 0.3 mL, 0.5 mL, and 1 mL Syringes The most commonly used small-volume syringe sizes for peptide-related supplies are 0.3 mL, 0.5 mL, and 1 mL
Both products were marketed and sold without prescriptions, without medical oversight, and without the regulatory framework that governs legitimate pharmaceutical distribution
Get Support Events Get Involved About Sign in Donate Related Articles Autism Facts1 min read Theater-based social skills interventions show improvements in social communication and cognition in youth with autism Autism Facts1 min read Some children with autism have significantly higher ammonia levels in their blood Autism Facts1 min read A gluten-free, casein free diet can reduce stereotypical behaviors and enhance cognition